Skip to main content
Clinical Trials/NCT04113902
NCT04113902
Completed
Not Applicable

The Effects of Health Education About Human Papilloma Virus and Cervical Cancer Prevention on Knowledge, Attitudes, Beliefs and Behaviors of Adolescent Girls and Their Mothers: A Prospective Randomized Controlled Study

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi1 site in 1 country216 target enrollmentDecember 18, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Health Education
Sponsor
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Enrollment
216
Locations
1
Primary Endpoint
Health Belief Model Scale for Human Papilloma Virus and Vaccine
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Aim: To determine the effects of health education about Human Papilloma Virus infection and cervical cancer prevention on knowledge, attitudes, beliefs and behaviors of adolescent girls and their mothers.

Background: To combat with cervical cancer, it is urgent that prevention Human Papilloma Virus related disease all around the world.

Design: A randomized trial with a control group (n=108) and an intervention group (n=108).

Methods: The study was applied between January to June 2019 in the two different adolescent outpatient clinics in Turkey. The outpatient clinics were randomly assigned as intervention and control groups by numbering and opaque and sealed envelopes. Based on the intention-to-treat principle, all participants were analyzed according to the group they were assigned to, regardless of whether they received the intervention or not. In addition to the routine clinical practice, the adolescent girls and their mothers who participated in the intervention group were given health education twice in the first interview and in the fifth week. Follow-up continued for 12 weeks. The adolescent girls and their mothers in the control group received routine clinical practice. The effects of health education were evaluated with Human Papilloma Virus Knowledge Scale and Health Belief Model Scale for Human Papilloma Virus and its Vaccination.

Impact: Human Papilloma Virus vaccine, which has an important place in primary protection from cervical cancer, is expected to provide effective results by facilitating access to vaccine accompanied with health education.

Registry
clinicaltrials.gov
Start Date
December 18, 2018
End Date
May 15, 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Saglik Bilimleri Universitesi Gulhane Tip Fakultesi
Responsible Party
Principal Investigator
Principal Investigator

Serpil Ozdemir, PhD, RN

Assistant Professor

Saglik Bilimleri Universitesi Gulhane Tip Fakultesi

Eligibility Criteria

Inclusion Criteria

  • To be a girl between the ages of 9 and 18, to be a mother of a girl between the ages of 9 and 18, to be fluent in Turkish, to be literate

Exclusion Criteria

  • to be male, to have previously received Human Papilloma Virus vaccination, to have hearing, speech impairment and mental disorder, not to follow the study regularly, to use medication due to psychotic treatments, to be an adolescent with sexual experience

Outcomes

Primary Outcomes

Health Belief Model Scale for Human Papilloma Virus and Vaccine

Time Frame: three months

In the four-point Likert scale, each item is scored between "none = 1" and "too much = 4.. The lowest score is 14 and the highest score is 56.

Human Papilloma Virus Knowledge Scale

Time Frame: three months

True 1 "points are given to the correct answers given by the participants to each item, and" 0 "points are given to wrong and undecided' 'answers with incorrect answers. The lowest score that can be obtained from the scale is "0" and the highest is "10".

Secondary Outcomes

  • Health Belief Model Scale for Human Papilloma Virus and Vaccine(three months)
  • Human Papilloma Virus Knowledge Scale(three months)

Study Sites (1)

Loading locations...

Similar Trials